Versor Investments LP Harmony Biosciences Holdings, Inc. Transaction History
Versor Investments LP
- $623 Million
- Q3 2024
A detailed history of Versor Investments LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Versor Investments LP holds 14,284 shares of HRMY stock, worth $497,511. This represents 0.09% of its overall portfolio holdings.
Number of Shares
14,284
Previous 18,210
21.56%
Holding current value
$497,511
Previous $549,000
3.83%
% of portfolio
0.09%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
243Shares Held
45.2MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$391 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$203 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$121 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$90.8 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$67.2 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.06B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...